DMAC Competitors & Alternatives
Compare DiaMedica Therapeutics Inc with similar stocks in the same industry
Biotechnology
DMAC
Main Stock$6.32
Tradestie Score
61
Market Cap
$354.59M
Analyst Upside
+145.3%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$14.22
|
$386.68M | - | 60 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$8.40
|
$382.04M | - | 57 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$8.51
|
$371.64M | - | 54 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$30.38
|
$357.51M | - | 50 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$14.55
|
$354.45M | - | 55 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$31.97
|
$353.70M | - | 59 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.86
|
$350.98M | - | 52 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$3.09
|
$341.56M | - | 58 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.69
|
$332.96M | - | 53 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$14.53
|
$308.74M | - | 58 | Compare |
More DMAC Analysis
Data updated: May 09, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry